Patents by Inventor Ravi Jain

Ravi Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8101743
    Abstract: Compounds, compositions and methods are provided for modulating the expression of transthyretin. The compositions comprise oligonucleotides, targeted to nucleic acid encoding transthyretin. Methods of using these compounds for modulation of transthyretin expression and for diagnosis and treatment of diseases and conditions associated with expression of transthyretin are provided.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: January 24, 2012
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Vickie L. Brown-Driver, Ravi Jain
  • Patent number: 8067386
    Abstract: Compounds, compositions and methods are provided for modulating the expression of eIF4E-BP2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding eIF4E-BP2. Methods of using these compounds for modulation of eIF4E-BP2 expression and for diagnosis and treatment of diseases and conditions associated with expression of eIF4E-BP2 are provided.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: November 29, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Sanjay Bhanot, Kenneth W. Dobie, Ravi Jain
  • Publication number: 20110288931
    Abstract: This specification describes technologies relating to content presentation. In general, one aspect of the subject matter described in this specification can be embodied in methods that include the actions of generating a directed graph of a mobile application, each node of the directed graph corresponding to an annotated page view of the mobile application; converting, using one or more processors, the directed graph into a microsite of the mobile application; crawling the microsite to identify keywords for the mobile application; and using the identified keywords to identify candidate advertisements to present to users of the mobile application. Other embodiments of this aspect include corresponding systems, apparatus, and computer program products.
    Type: Application
    Filed: May 20, 2010
    Publication date: November 24, 2011
    Applicant: GOOGLE INC.
    Inventors: Christina Kuhn, Ravi Jain
  • Publication number: 20110288615
    Abstract: A neurostimulation array comprising a first implantable neurostimulator storing a first identification code in a non-volatile memory and responding to communications including said first identification code, a second implantable neurostimulator storing a second identification code in a non-volatile memory and responding to communications including said second identification code, and a polymer connector attached to said first implantable neurostimulator and said second implantable neurostimulator, thereby forming a neurostimulation array.
    Type: Application
    Filed: April 27, 2011
    Publication date: November 24, 2011
    Applicants: The Board of Regents, The University of Texas System, MicroTransponder, Inc.
    Inventors: Scott Armstrong, Lawrence J. Cauller, Ravi Jain, David Michael Pierce, Guenter H. Lehman
  • Publication number: 20110270673
    Abstract: In general, this specification relates to content presentation. One aspect of the subject matter described in this specification can be embodied in methods that include the actions of presenting one or more content items to a user, each content item being associated with a conversion location; logging an identifier for each of the one or more content items presented to the user; receiving a location and user identifier from the user; using the user identifier to identify the one or more content items presented to the user and comparing, using one or more processors, the location to the conversion location of the one or more content items presented to the user; and logging a conversion for a particular presented content item having a conversion location matching the received location. Other embodiments of this aspect include corresponding systems, apparatus, and computer program products.
    Type: Application
    Filed: April 30, 2010
    Publication date: November 3, 2011
    Applicant: GOOGLE INC.
    Inventors: Jennifer W. Lin, Anita Krishnakumar, Ravi Jain
  • Publication number: 20110224277
    Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.
    Type: Application
    Filed: December 31, 2008
    Publication date: September 15, 2011
    Applicant: REGULUS THERAPEUTICS, LLC.
    Inventors: Christine Esau, Bridget Lollo, C. Frank Bennett, Susan M. Freier, Richard H. Griffey, Brenda F. Baker, Timothy A. Vickers, Eric G. Marcusson, Erich Koller, Eric E. Swayze, Ravi Jain, Balkrishen Bhat, Eigen Peralta
  • Patent number: 8017405
    Abstract: The present invention provides a method for analyzing gases such as carbon dioxide, and includes passing a gas stream containing impurities into a gas adsorption means for a length of time at ambient or higher temperatures to adsorb the impurities therein, stopping the flow of the gas stream, and desorbing and analyzing the impurities using a detector.
    Type: Grant
    Filed: August 7, 2006
    Date of Patent: September 13, 2011
    Assignee: The BOC Group, Inc.
    Inventors: Ravi Jain, YuDong Chen
  • Patent number: 7983691
    Abstract: This specification describes technologies relating to geographically localizing mobile communication devices. In general, one aspect of the subject matter described in this specification can be embodied in a method that includes receiving information corresponding to a location of a wireless landmark in a mobile communication network. The method also includes communicating with the wireless landmark to estimate the location of a first node in the mobile communication network proximate to the wireless landmark. Other embodiments of this aspect include corresponding systems, apparatus, and computer program products.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: July 19, 2011
    Assignee: Google Inc.
    Inventors: Bernard Wong, Samir Goel, Ravi Jain
  • Patent number: 7978647
    Abstract: The invention is addressing the problem of efficient formation and maintenance of piconets with assistance from the master of an already existing piconet. The master of an existing piconet initiates the formation of a new helper piconet by at least two of its slaves. One of the slaves of the existing piconet becomes the master of the newly formed helper piconet and the other slave becomes a slave of the helper piconet. This process can be used to expand the number of Bluetooth devices that can use an Internet access point. It can also be used to permit two slave devices to communicate directly with one another so as not to unnecessarily use bandwidth available through the master. Finally, the method and system could be used to provide a method of efficient hand-off from one piconet to another.
    Type: Grant
    Filed: October 11, 2007
    Date of Patent: July 12, 2011
    Assignee: TTI Inventions C LLC
    Inventors: Farooq Anjum, Ravi Jain, Maria Adamou
  • Publication number: 20110137392
    Abstract: A cardio electrotherapy lead is disclosed herein. In one embodiment, the lead includes a tubular body, a conductor cable and an electrode. The conductor cable longitudinally extends through the tubular body and includes a distal end. The electrode is located on the tubular body and includes an attachment mechanism mechanically coupling the lead distal end to the electrode.
    Type: Application
    Filed: February 17, 2011
    Publication date: June 9, 2011
    Applicant: PACESETTER, INC.
    Inventors: Matt Randle, Ravi Jain, Peter Fong
  • Publication number: 20110112171
    Abstract: Disclosed herein are compounds, compositions and methods for modulating the expression of PTPRU in a cell, tissue or animal. Also provided are methods of active target segment validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Also provided are methods for the prevention, amelioration and/or treatment of diabetes, obesity, insulin resistance, insulin deficiency, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hyperfattyacidemia, liver steatosis, steatohepatitis, non-alcoholic steatohepatitis, metabolic syndrome, cardiovascular disease and coronary heart diseaseby administration of antisense compounds targeted to PTPRU.
    Type: Application
    Filed: January 19, 2011
    Publication date: May 12, 2011
    Applicant: Isis Pharmaceuticals, Inc.
    Inventors: Robert McKay, Ravi Jain, Kenneth W. Dobie, Sanjay K. Pandey, Sanjay Bhanot
  • Publication number: 20110092572
    Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
    Type: Application
    Filed: November 23, 2010
    Publication date: April 21, 2011
    Applicants: Antisense Therapeutics Limited, Isis Pharmaceuticals, Inc.
    Inventors: George Tachas, Kenneth W. Dobie, Ravi Jain, Christopher Belyea, Mark Heffernan
  • Patent number: 7912557
    Abstract: A cardio electrotherapy lead is disclosed herein. In one embodiment, the lead includes a tubular body, a conductor cable and an electrode. The conductor cable longitudinally extends through the tubular body and includes a distal end. The electrode is located on the tubular body and includes an attachment mechanism mechanically coupling the lead distal end to the electrode.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: March 22, 2011
    Assignee: Pacesetter, Inc.
    Inventors: Matt Randle, Ravi Jain, Peter Fong
  • Patent number: 7897583
    Abstract: Disclosed herein are compounds, compositions and methods for modulating the expression of PTPRU in a cell, tissue or animal. Also provided are methods of active target segment validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Also provided are methods for the prevention, amelioration and/or treatment of diabetes, obesity, insulin resistance, insulin deficiency, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hyperfattyacidemia, liver steatosis, steatohepatitis, non-alcoholic steatohepatitis, metabolic syndrome, cardiovascular disease and coronary heart disease by administration of antisense compounds targeted to PTPRU.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: March 1, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Robert McKay, Ravi Jain, Kenneth W. Dobie, Sanjay K. Pandey, Sanjay Bhanot
  • Patent number: 7890190
    Abstract: A body implantable lead system includes an over-the-wire lead with a longitudinally extending lumen. A hollow stylet having an outer peripheral surface is introduced into the lumen and an annular resilient blood seal within the lumen may be sealingly positioned between the outer peripheral surface of the stylet and the lead to prevent flow of blood beyond the blood seal and into the lumen in a proximal direction. A guidewire is slidably received within the hollow stylet and includes a tip end which may project through the passage at the distal end of the lead such that relative movement of the guidewire and stylet within the lead is enabled while avoiding friction between the blood seal and the guidewire. Either the guidewire or the stylet may be preshaped for proper placement of the lead for engagement with the body tissue and surrounded by a semi-rigid retractable sheath.
    Type: Grant
    Filed: February 20, 2007
    Date of Patent: February 15, 2011
    Assignee: Pacesetter, Inc.
    Inventors: Scott Salys, Ravi Jain
  • Patent number: 7846906
    Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: December 7, 2010
    Assignees: Isis Pharmaceuticals, Inc., Antisense Therapeutics Limited
    Inventors: Kenneth Dobie, Ravi Jain
  • Publication number: 20100292140
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 4. Methods of using these compounds for modulation of fibroblast growth factor receptor 4 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 4 are provided.
    Type: Application
    Filed: October 1, 2008
    Publication date: November 18, 2010
    Inventors: Sanjay Bhanot, Xing-Xian Yu, Susan M. Freier, Ravi Jain
  • Publication number: 20100290977
    Abstract: There is provided a method for purifying a gas stream such as for example a carbon dioxide gas stream by removing hydrocarbons from the carbon dioxide by heat exchange, impurity adsorption and cooling.
    Type: Application
    Filed: May 15, 2009
    Publication date: November 18, 2010
    Inventors: Charles W. BOWERS, William R. Gerristead, JR., Ravi Jain, Yudong Chen
  • Publication number: 20100286899
    Abstract: A computer-implemented method includes obtaining road sensor data reflecting speeds of traffic on road segments, transforming the road sensor data using vehicle probe data for the road segments reflecting vehicle speeds, and producing speed estimates for the road segments using the transformed road sensor data. The method can further include determining speeds for road segments between road sensors by smoothing data from sensors near the road segments.
    Type: Application
    Filed: August 15, 2008
    Publication date: November 11, 2010
    Applicant: GOOGLE INC.
    Inventors: Ravi Jain, Samir Goel, Gregory Neverov
  • Publication number: 20100267813
    Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.
    Type: Application
    Filed: December 31, 2008
    Publication date: October 21, 2010
    Applicant: REGULUS THERAPEUTICS, LLC.
    Inventors: Christine Esau, Bridget Lollo, C. Frank Bennett, Susan M. Freier, Richard H. Griffey, Brenda F. Baker, Timothy A. Vickers, Eric G. Marcusson, Erich Koller, Eric E. Swayze, Ravi Jain, Balkrishen Bhat, Eigen Peralta